Ashraf Reyad, MD
Transplant Surgery · McAllen, TXNPI 1518273986
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (54.8%), food and beverage and education — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 63.2% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $934 and has fallen 87.6% since, to $115 in 2025. That places this record below the midpoint for transplant surgery clinicians in TX, where the typical reported total is $2,154.
Across 14 payments — averaging $101.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$895
- Calliditas Therapeutics US Inc.$141
- Sanofi-aventis U.S. LLC$132
- Apellis Pharmaceuticals, Inc.$115
- Veloxis Pharmaceuticals, Inc.$56
- Medtronic$38
- plus $38 from 2 others
What the payments were for
- Travel & lodging$77755%
- Food & beverage$58441%
- Education$564%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 6 | $895 |
| Calliditas Therapeutics US Inc. | 1 | $141 |
| Sanofi-aventis U.S. LLC | 2 | $132 |
| Apellis Pharmaceuticals, Inc. | 1 | $115 |
| Veloxis Pharmaceuticals, Inc. | 1 | $56 |
| Medtronic | 1 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Shire North American Group Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$758
- TARPEYO$141
How this compares
$1,417 in reported general payments places this provider in the 40th percentile of 70 transplant surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other transplant surgery in McAllen
- Sridhar AllamMcAllen$392K
- Jose Valdes BracamontesMcAllen$1K
- Eduardo FernandesMcAllen$442
- Philip ThomasMcAllen$338
- Rafik GhobrialHouston$144K
- Goran KlintmalmDallas$88K
- Constance MobleyHouston$56K
- David HallHouston$43K
- Ahmed GaberHouston$35K
- Nhu Thao GalvanHouston$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.